More articles from Bench to Bedside
- Potential molecular therapy for acute renal failure
As more is learned about renal epithelial cell regeneration and differentiation, exogenously administered growth promoters seem a likely intervention.
- Myasthenia gravis therapy: immunoadsorbent may eliminate need for plasma products
This new technique accomplished nearly complete removal of anti-acetylcholine receptor antibody with minimal loss of albumin.
- Calcium-channel blocking agents as therapy for amphotericin B nephrotoxicity
Concomitant use of calcium-channel blockers may prevent nephrotoxicity and permit use of full therapeutic doses of amphotericin B in systemic fungal infection.
- Use of angiotensin-converting enzyme inhibitors in chronic progressive renal disease
In chronic renal disease, ACE inhibition may counteract certain changes that lead to end-stage renal failure.
- A new intracellular flush solution improves renal transplant preservation
A new renal preservation flush solution minimizes the ischemic injury that occurs during hypothermic storage and reperfusion.
- Lipoprotein abnormalities in the progression of renal disease
Animal models suggest that lipid-dowering agents may benefit patients with chronic progressive renal disease.
- New Series
An innovative series will address issues in basic science that are relevant to the practice of medicine.
- Intra-arterial chemotherapy for brain tumors
A program involving rabbit and human protocols demonstrates the successful integration of basic and clinical research with practical applications.